Akamis Bio

Abingdon, United Kingdom

Akamis Bio is a clinical-stage oncology company.

$60.0M raised

Dec 2024

Series A

Top Investors

InvescoSR OneARCH Venture PartnersBristol-Myers SquibbSalica

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Akamis Bio raised?

Akamis Bio has raised $60.0M in total funding. The most recent round was Series A. The last funding was announced in December 2024.

Who are Akamis Bio's investors?

Akamis Bio's investors include Invesco, SR One, ARCH Venture Partners, Bristol-Myers Squibb, Salica.

Where is Akamis Bio headquartered?

Akamis Bio is headquartered in Abingdon, United Kingdom.

What does Akamis Bio do?

Akamis Bio is a clinical-stage oncology company.

What stage is Akamis Bio at?

Akamis Bio is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 17, 2024.

MLA

"Akamis Bio — Funding & Investors." VCBacked, December 17, 2024, https://www.vcbacked.co/company/akamis-bio. Accessed June 3, 2026.

APA

VCBacked. (2024). Akamis Bio — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/akamis-bio

Wikipedia (cite web)

{{cite web |title=Akamis Bio — Funding & Investors |url=https://www.vcbacked.co/company/akamis-bio |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 17, 2024.